Evolus, Inc.
EOLS
Peringkat dalam Saham
#12986
Evolus, Inc. is a performance beauty enterprise that furnishes the United... Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Harga Saham
$7.49
Kapitalisasi Pasar
$494.72M
Perubahan (1 hari)
1.22%
Perubahan (1 tahun)
-48.63%
Negara
US
Perdagangan Evolus, Inc. (EOLS)
Kategori
Healthcare
Riwayat harga saham Evolus, Inc. (EOLS)
Harga penutupan tertinggi: $12.39 pada 2025-01-01
Harga penutupan terendah: $19.84 pada 2018-08-01
Harga penutupan terendah: $19.84 pada 2018-08-01
Riwayat harga saham Evolus, Inc. dari 2018 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2025 | 3.66% |
| 2024 | 20.62% |
| 2023 | 39.40% |
| 2022 | 15.12% |
| 2021 | -56.66% |
| 2019 | -3.72% |
| 2018 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
